Read original ↗
paperarXivTrust 82 · PrimaryPublished 2d agoLive · 46m ago

Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Guidance

Hepatocellular carcinoma (HCC) is a common malignancy and a leading cause of cancer-related mortality. Current guidelines and staging systems provide coarse categories, but often miss within-stage heterogeneity and the clinical context in electronic medical records (EMRs). We present HCC-STAR (Hepatocellular Carcinoma Staging, Treatment And pRognosis), a clinically aligned large language model that reads routine EMR narratives and jointly outputs risk score-based staging, ranked guideline-consistent treatments with evidence-based rationales, and individualized survival estimates. We curated ab

Lineage graph

Paper → model → repo connections mined from source citations (Tier-1 exact match).

Why these links exist

  • Linked via arxiv authorZhaopeng Cui

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorJitao Wang

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorSiyan Xue

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorYao Huang

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorHaoming Xia

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorDong Liang

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorDengxiang Liu

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorWeilin Wang

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorLiping Liu

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorLeida Zhang

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorYunfu Cui

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorTao Peng

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorDaolin Ji

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorHaitao Zhao

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorJiawei Zhang

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorXiaojuan Wang

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorWeijie Ma

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorZongren Ding

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorJinlong Li

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorYuan Ding

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorJiajing Zhao

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorZhiyu Chen

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorChengkun Yang

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorZiyue Huang

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorJiaqi Liu

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorFusheng Liu

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorYang Zhou

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorZhongquan Sun

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorShiyun Bao

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorXiaojun Wang

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorMing Yang

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorGuangxin Li

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorBin Shu

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorYong Liao

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorHongxuan Li

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorChengyao Tang

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorShizhong Yang

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorYongyi Zeng

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorYufeng Yuan

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorYinpeng Dong

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorJihui Hao

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorJun Zhu

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

  • Linked via arxiv authorJiahong Dong

    Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Gu

Covers

authored (incoming)

Covers (incoming)

Related across the graph

Topics